FRIDAY, Oct. 16, 2020 -- The number of new U.S. coronavirus cases topped 60,000 on Thursday, a tally not reported since early August, as health experts worried the coming winter might push the toll even higher.
The latest numbers have also sent the cou
TARRYTOWN, N.Y., Oct. 14, 2020 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that the U.S. Food and Drug Administration (FDA) approved Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn) for the treatment of infection ca
FRIDAY, Oct. 16, 2020 -- An experimental COVID-19 vaccine appeared to be safe and triggered an immune response in healthy people, according to preliminary results of a small, early-stage clinical trial.
The study of the vaccine based on inactivated who
Averitas Pharma Announces FDA Approval of Qutenza for the Treatment of Neuropathic Pain Associated with Diabetic Peripheral Neuropathy of the Feet
AACHEN, Germany and MORRISTOWN, N.J., July 21, 2020 /PRNewswire/ -- Grünenthal announced today that its U.S
COVID-19 Jitters Shouldnt Keep You From the Emergency Room
THURSDAY, July 23, 2020 -- Fear of COVID-19 is keeping keep some people from getting medical help for critical conditions like stroke and heart attack, experts say.
In the first months of the
Opioid Pain Relievers or Medicines to Treat Opioid Use Disorder - FDA Recommends Health Care Professionals Discuss Naloxone with All Patients when Prescribing
Audience: Consumer, Health Professional, Pharmacy
ISSUE: FDA is requiring drug manufacturers